June 15, 2026 Announcement no. 13 Grant of Warrants Copenhagen, Denmark, June 15, 2026, (GLOBE NEWSWIRE) – The Board of…
MRD has scaled into a profitable, category-leading MRD diagnostics business, while Immune Medicine has built a differentiated discovery platform powered…
June 15, 2026 16:05 ET | Source: Adaptive Biotechnologies Proceeds expected to be deployed to repay the OrbiMed Purchase Agreement…
The companies will combine their complementary expertise in synthetic oligosaccharides, conjugation process development and GMP vaccine manufacturing to support partners…
BEIJING, June 15, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the…
Poster presentations from ongoing clinical trials of two core assets, olverembatinib and lisaftoclax, highlight global innovation capabilities in hematologic malignancies…
Achieved 100% ORR and 83.3% CR rate at dose level 2 following a single infusion in patients with relapsed/refractory B-NHL…
RIYADH, Saudi Arabia, June 14, 2026 (GLOBE NEWSWIRE) -- At HLTH Europe 2026 in Amsterdam, taking place from June 15…
June 13, 2026 16:00 ET | Source: Ascendis Pharma Multi-organ system and quality-of-life benefits sustained through three and a half…
-- Patients with PWS treated with setmelanotide therapy (N=17) achieved clinically meaningful BMI or BMI z-score reductions, reductions in fat…